Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLONAZEPAM Cause Economic problem? 13 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Economic problem have been filed in association with CLONAZEPAM (Clonazepam). This represents 0.0% of all adverse event reports for CLONAZEPAM.

13
Reports of Economic problem with CLONAZEPAM
0.0%
of all CLONAZEPAM reports
1
Deaths
4
Hospitalizations

How Dangerous Is Economic problem From CLONAZEPAM?

Of the 13 reports, 1 (7.7%) resulted in death, 4 (30.8%) required hospitalization, and 7 (53.8%) were considered life-threatening.

Is Economic problem Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLONAZEPAM. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does CLONAZEPAM Cause?

Drug ineffective (5,088) Toxicity to various agents (4,028) Completed suicide (3,320) Drug abuse (3,287) Off label use (2,590) Anxiety (2,376) Somnolence (2,260) Dyspnoea (1,987) Depression (1,838) Insomnia (1,836)

What Other Drugs Cause Economic problem?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,945) ARIPIPRAZOLE (1,548) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (1,453) TESTOSTERONE (1,028) TENOFOVIR DISOPROXIL (907) COPPER (797) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (679) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (403) TEPROTUMUMAB-TRBW (99) ANDROGEL (81)

Which CLONAZEPAM Alternatives Have Lower Economic problem Risk?

CLONAZEPAM vs CLONIDINE CLONAZEPAM vs CLOPIDOGREL CLONAZEPAM vs CLOPIDOGREL BESILATE CLONAZEPAM vs CLOPIDOGREL BISULFATE CLONAZEPAM vs CLORAZEPATE

Related Pages

CLONAZEPAM Full Profile All Economic problem Reports All Drugs Causing Economic problem CLONAZEPAM Demographics